None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Patients who will undergo endoscopic treatment for an established or suspected rectal neuroendocrine tumor (NET) ? Patients with an age of 20 to 79 years ? Patients who provided informed consent for this study.
Exclusion criteria
Exclusion criteria: ? An established or suspected rectal NET larger than or equal to 10 mm in endoscopically measured size. ? A incompletely resected rectal NET after a previous therapeutic endoscopic interventio that requires endoscopic submucosal dissection, instead of EMR or modified EMR techniques. ? Without trying precut EMR or ASEMR (interventions for this study), endoscopic submucosal dissection was performed because of the inadequate lifting of the lesion after submucosal injection ? Platelet count less than 80,000/uL or Prolonged PT (over 50%) in the laboratory tests checked within 6 months before the intervention. ? Medical history of other known coagulopathy ? Patients who do not provide informed consent for this study ? Patients who do not show on the scheduled date for intervention and do not undergo the assigned intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Histologic complete resection rate (per protocol analysis: only include rectal NETs in the final histologic report) | — |
Secondary
| Measure | Time frame |
|---|---|
| Procedure completion rate (intention-to-treat for all lesions / per protocol analysis for the lesions with NETs in the final diagnosis);Resection time (intention-to-treat for all lesions / per protocol analysis for the lesions with NETs in the final diagnosis);Procedure time including endoscopic hemostasis time (intention-to-treat for all lesions / per protocol analysis for the lesions with NETs in the final diagnosis);Adverse event rate (intention-to-treat for all lesions / per protocol analysis for the lesions with NETs in the final diagnosis) | — |
Countries
Korea, Republic of
Contacts
Asan Medical Center